MyHPVscore Test
MyHPVscore Test
What is MyHPVscore?
MyHPVscore™ is a reliable blood test that helps detect HPV-driven head and neck cancers. Using advanced technology, MyHPVscore™ measures fragments of circulating HPV DNA, a marker shed by cancer cells into the blood. This test is highly accurate, making it a dependable tool for uncovering HPV-positive head and neck cancers at various stages of care.
With MyHPVscore™, you can gain valuable insights into your health and take proactive steps towards managing HPV-related cancers effectively.
What is human papillomavirus (HPV)?
Human papillomavirus (HPV) is one of the most common sexually transmitted infections (STIs). It is a virus that can be spread through skin-to-skin genital contact. There are many different types of HPV. Some types cause genital warts and are called low-risk. And some types can lead to cervical, anal, or mouth (oral) cancer and are called high-risk. Other types of HPV cause common, plantar, and filiform or flat warts. These types of warts are not cancerous.
There is no known cure for HPV, but there is a vaccine that can help protect against some types of the virus.
What are the benefits of MyHPVscore?
Overall, HPV ctDNA tests from plasma offer a non-invasive and sensitive approach for detecting HPV ctDNA in individuals at risk of HPV-related cancers, potentially enabling earlier diagnosis of disease recurrence and personalized management of the disease. However, it's essential to interpret the results of this lab developed test within the context of the patient's clinical history and other diagnostic findings for accurate assessment and appropriate management.
Request a MyHPVscore test
Request a MyHPVscore test by emailing a representative.
Resources
Researchers who developed the MyHPVscore test:
- Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma
- Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma
- Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma
News & Stories
Many young adults favor at-home STI testing for convenience and privacy
Self-sampling for HPV screening found to be as effective as speculum exams
Speculum exams unnecessary for HPV screening
First-of-its-kind blood test for head and neck cancer
Improving access to HPV testing